HSPB1 and lung cancer: We found that the genetic polymorphism of HSPB1 rs2070804 (G>T) was significantly associated with the overall survival (OS) of lung cancer patients in additive and dominant models [Additive model: p=0.041, OR=0.66, 95%CI, (0.45–0.98); Dominant model: p=0.015, OR=0.55, 95%CI, (0.34–0.89)].